In this issue of Heart we have the opportunity to enjoy the results of a study on sudden cardiac arrhythmic death coming from a group with a longstanding experience in the diagnosis and treatment of this condition.1 Since the recognition of the genetically determined disease now known as “Brugada syndrome”,2 a lot of effort has been dedicated to understanding the pathophysiologic basis and prognosis of this and other primary electrical diseases of the heart. Viskin and colleagues now provide us with an additional and very important piece of information. By comparing a group of patients with the disease to a sufficiently large control group of individuals, they show that the ECG is a powerful tool to recognise …